Each session includes a presentation and short discussion and lasts about 1 hour
| Date | Presenter / Topic | Register |
|---|---|---|
Andrew Goetz - Department of Biomedical Engineering, Yale University, New Haven, CT, US
|
||
|
||
Heather Collis, Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden
|
||
Valeriu Damian
|
||
We are taking a short break for July. Check back later for our August Webinar details!
|
||
K. Melissa Hallow, PhD
|
||
Dr. Robert Sheehan
|
||
Dr. Michael Monine
|
||
Amy Moody, PhD
|
||
Brian Topp
|
||
Tom Yankeelov, Ph.D.
|
||
Norman A. Mazer, M.D., Ph.D.
|
||
Jiawei Zhou, PhD
|
||
Mikael Boberg, PhD
|
||
Sheena Sharma, PhD
|
||
Robin T.U. Haid, MSc
|
||
Dr. Marcus Rosenblatt, PhD
|
||
Jared Weddell, Ph.D.
|
||
Robert R. Bies, Pharm.D. Ph.D. FISoP
|
||
Rebecca Baillie, PhD, Christina Friedrich, PhD, Jake Nichols, PharmD, MBA
|
||
Natalie Morris, BSc
|
||
Vincent Lemaire, Ph.D.; Fei Hua, Ph.D.
|
||
Dr Dinko Rekic, PhD and Dr Jane Knöchel, PhD
|
||
The team is taking some time to spend with their families.
|
||
Chuanpu Hu, PhD
|
||
Wojciech Krzyzanski PhD, MA
|
||
Philippe Moingeon PhD, MBA
|
||
Bill Brastow, Ph.D.
|
||
• Christina Friedrich, PhD, Chief Engineer, Rosa & Co, San Carlos, CA• Stephen Duffull, PhD, Professor, (1) Senior Scientific Advisor, Certara, (2) Otago Pharmacometrics Group, School of Pharmacy, University of Otago, Dunedin, New Zealand• Theodor
|
||
Stefano Morotti, PhD.
|
||
Chuanpu Hu, PhD.
|
||
Joga Gobburu
|
||
Nick Holford, Emeritus Professor
|
||
Christina Friedrich, PhD; Jérémy Huard
|
||
Check back soon for more webinars.
|
||
Dr. Dipak Barua
|
||
James Lu, PhD
|
||
Dr Adam Palmer
|
||
Yanguang (Carter) Cao, PhD.
|
||
Tongli Zhang, PhD
|
||
Anastasios Siokis, PhD
|
||
Vincent Hurez, DVM, PhD
|
||
Thorsten Lehr, PhD
|
||
Amber Smith, PhD.
|
||
Bill Brastow, PhD
|
||
Bill Brastow, PhD
|
||
Paul B. Watkins, M.D. FAASLD.
|
||
Luca Gerosa, PhD
|
||
Katherine Kudrycki, PhD
|
||
Eric Sobie, PhD
|
||
Dr. Jonathan E. Allen
|
||
Dr. Bill Brastow
|
||
Stacey Tannenbaum, PhD, FISoP
|
||
Iraj Hosseini, PhD and Justin Feigelman, PhD
|
||
Paolo Denti, PhD
|
||
Sergio Iadevaia, PhD
|
||
Rajanikanth (Raj) Madabushi, PhD
|
||
Jeffrey R. Sachs, Ph.D.
|
||
Sietse Braakman, PhD
|
||
Dr. Britta Goebel
|
||
Robert Bies, Pharm.D. Ph.D
|
||
James Yates, MMath, PhD
|
||
Maria Trujillo PhD
|
||
Loveleena Bansal, PhD
|
||
Vivaswath S. Ayyar, Ph.D.
|
||
Dr.-Ing. Markus Rehberg
|
||
Stephan Schmidt, B.Pharm, Ph.D., F.C.P.
|
||
Professor Ioannis (Yannis) P. Androulakis
|
||
Chi-Chung Li, Ph.D., Senior Scientist, Clinical Pharmacology, and Iraj Hosseini, PhD. Scientist
|
||
Eric Sobie, PhD, Professor, Pharmacological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY
|
||
Theresa Yuraszeck, Associate Director, Quantitative Pharmacology, CSL Behring
|
||
Richard Gliklich, MD, Founder and CEO, OM1
|
||
Iraj Hosseini, PhD. Scientist at Genentech
|
||
Prasad Dhurjati, PhD, Professor of Chemical & Bio-molecular Engineering, Joint appointment as Professor Biological Sciences and Professor of Mathematical Sciences, University of Delaware
|
||
1) Lealem Mulugeta, Executive Committee Member of CPMS, Founder/Executive of InSilico Labs and Medalist Fitness.2) Andrew Drach, Senior Research Fellow at University of Texas at Austin, Executive Committee Member of CPMS
|
||
Aman Singh, PK-PD Scientist, Biologics Development Sciences, Janssen R&D
|
||
Christina Friedrich, PhD, Chief Engineer, and Mike Reed, PhD, Chief Scientist, Rosa & Co, CA
|
||
Richard A. Gray, PhD, Senior Research Biomedical Engineer, Food and Drug Administration, Silver Spring, MD
|
||
Chihiro Hasegawa, PhD, PK/PD Scientist, Ono Pharma, Japan, Otago Pharmacometrics Group, School of Pharmacy, University of Otago, New Zealand
|
||
Frank Gibbons, PhDPrincipal Scientist, DMPK, IMED Oncology Biotech UnitAstraZeneca
|
||
Sietse Braakman, PhDMathWorks
|
||
Dr. Ryan TasseffScientistProcter and Gamble
|
||
Konstantinos (Kostas) Biliouris, PhD Principal Pharmacometrics Scientist Novartis Cambridge, MA, USA
|
||
Nelleke Snelder Senior Consultant LAP&P Consultants BV Leiden, The Netherlands
|
||
Joga Gobburu, PhD, Division of Parmacometrics, OCP/FDA
|
||
Dr. Valeriu Damian-Iordache, Director Pharmacokinetics and Translational Biology, GlaxoSmithKline
|
||
Dr. Scott Q Siler, Lead DILI-sim Consultant
|
||
Dr. Toufigh Gordi, Rosa and Co.; President, PK/PD and Clinical Pharmacology Services
|
||
Dr. Birgit Schoeberl; Vice President of Discovery; Merrimack Pharmaceuticals
|
||
Joga Gobburu, PhD FCP MBA; School of Pharmacy|School of Medicine, Univ. of Maryland, Baltimore
|
||
Hartmut Derendorf, PhD; University of Florida, Gainesville
|
||
Tristan Maurer, PharmD, PhD; Research Fellow at Pfizer Pharmaceuticals
|
||
William J. Jusko, PhD, SUNY (Buffalo)
|
||
Christina Friedrich, PhD, Rosa & Co
|
||
Nick Holford, MBChB, University of Auckland, New Zealand
|
||
Herbert Sauro, PhD, University of Washington, Seattle
|
||
Rebecca Baillie, PhD, Rosa & Co
|
||
Rada Savic, PhD, Uppsala University
|
||
Dr. Frank Bergmann, University of Heidelberg
|
||
Tarek Leil, Director, Bristol-Myers Squibb
|
||
Robert Leipold, Research Scientist, Evidera
|
||
Dean Bottino, Head Modeling & Simulation Oncology at Roche Pharmaceuticals
|
||
Michael A. Eldon, Principal Scientific Fellow, VP, Clinical Pharmacology, Nektar Therapeutics
|
||
Christina Friedrich, Chief Engineer, Rosa and Co.
|
||
David J. Klinke II, Ph.D, Associate Professor, Chemical Engineering; West Virginia University
|
||
Dr. Chee Ng, Assistant Professor at Children's Hospital of Philadelphia
|
||
Dhavalkumar Shah, Senior Scientist; Modeling & Simulation, Pharmacokinetics, Dynamics, and Metabolism; Pfizer
|
||
Arthur Lo, Senior Scientist; Theravance
|
||
Pratap Singh, Ph.D, Senior Principal Scientist, Pfizer
|
||
Malcolm Rowland, PhD, Professor Emeritus, University of Manchester
|
||
Dr. Richard Peck, Global Head Clinical Pharmacology, Pharmaceutical Research and Development (pRED), Roche Products Ltd
|
||
Mike Reed, Chief Scientist, PhysioPD, Rosa & Co
|
||
Hugo Geerts Scientific Liaison Officer at In Silico Biosciences
|
||
Dhaval Shah Assistant Professor at SUNY Buffalo
|
||
Marc Birtwistle, PhD; Asst Professor, Pharmacology and Systems Therapeutics, Icahn School of Medicine, Mount Sinai, NY
|
||
Yu-Nien (Tom) Sun, Director, Quantitative Pharmacology Group; Pharmacokinetics & Drug Metabolism Department, Amgen, Inc.
|
||
Kapil Gadkar, Scientist at Genentech
|
||
C.J. Musante, Associate Research Fellow, Cardiovascular and Metabolic Diseases; Gianluca Nucci, Senior Director, Clinical Pharmacology, and Mark Peterson Director, Pharmacometrics, Pfizer Inc.
|
||
Thierry Lave, Head DMPK and TOX Project Leader and Modeling and Simulation, F. Hoffmann-La Roche
|
||
Ron Beaver, PhD, Founder, Chairman, and CEO, Rosa & Co LLC
|
||
Dr. Yanguang Cao, Research Assistant Professor, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, NY
|
||
Kosmas Kretsos, Associate Director, Global Exploratory Development, UCB New Medicines
|
||
Stephen Duffull, PhD, Chair of Clinical Pharmacy, Otago Pharmacometrics Group, School of Pharmacy, University of Otago, Dunedin, New Zealand
|
||
Ananth Kadambi, Ph.D., Senior Vice President, PhysioPD™, Rosa & Co.
|
||
Satyaprakash Nayak (Satya), Pharmacometrician - Systems Biologist at Pfizer
|
||
Peter L. Bonate, PhD, Senior Director, Astellas; Global Head - Pharmacokinetics, Modeling, and Simulation; Global Clinical Pharmacology & Exploratory Development
|
||
Eric A. Sobie Ph.D., Associate Professor, Dept. of Pharmacology and Systems Therapeutics; Icahn School of Medicine at Mount Sinai, NYC, NY
|
||
Loveleena Bansal, PhD, Post-Doctoral Researcher, GlaxoSmithKline
|
||
Dr. Ioannis (Yannis) P. Androulakis, Professor, Rutgers University, Piscataway, NJ
|
||
Samik Ghosh, PhD, The Systems Biology Institute, Tokyo, Japan
|
||
Sandra Visser, Principal Scientist, Early Stage Quantitative Pharmacology & Pharmacometrics, Merck
|
||
Michael Bolger, Ph.D., Chief Scientist and Ted Grasela, Ph.D., President, Simulations Plus; Lancaster, CA
|
||
Helen Moore, PhD, Associate Director, Quantitative Clinical Pharmacology, Bristol-Myers Squibb, Princeton, NJ
|
||
Christina Friedrich, PhD, Chief Engineer, Rosa & Co., San Carlos, CA and Fulden Buyukozturk, PhD, Technical Evangelist, MathWorks; Natick, MA
|
||
Melissa Hallow, Ph.D., Assistant Professor, College Of Engineering And Department Of Epidemiology And Biostatistics, University of Georgia, Athens, GA
|
||
Jonathan Wagg, MD, PhD, Disease Therapeutic Area Modeling Leader – Oncology, Roche Pharmaceutical Research and Early Development
|
||
Oliver Ghobrial, Sr. Scientist III, Systems Pharmacology/DMPK/PKPD, AbbVie, Inc.
|
||
Dr. Lourdes Cucurull-Sanchez, Senior Scientific Investigator; GlaxoSmithKline
|
||
Valeriu Damian, DirectorSystems Modeling and Translational Biology GlaxoSmithKline, King of Prussia, PA
|
||
Dr. Herbert Sauro, Associate Professor, Bioengineering, University of Washington
|
||
Aman P. Singh, PhD CandidateDepartment of Pharmaceutical Sciences, University at Buffalo, Buffalo, NY
|
||
Dr. Michael Weis, Senior Engineer, PhysioPD™, Rosa & Co.
|
||
Stacey Tannenbaum, PhD, FISoP Director: Pharmacokinetics, Modeling, and Simulation Clinical Pharmacology & Exploratory Development Astellas Pharma Global Development; Northbrook, IL
|
||
Natal van Riel, MSc, PhD Professor Computational Modelling
Associate Professor Systems Biology and Metabolic Disease
Eindhoven University of Technology, and Amsterdam Medical Center
Eindhoven, The Netherlands
|
||
Ben-Fillippo Krippendorff, Ph.D.Quantitative Systems Pharmacology, Pharmaceutical SciencesRoche Pharma Research & Early DevelopmentRoche Innovation Center Basel
|
||
Craig Thalhauser, Ph.D., Associate Director/Quantitative Clinical Pharmacology, Bristol-Myers Squibb, Princeton, NJ
|